Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19

The contagiosity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has startled mankind and has brought our lives to a standstill. The treatment focused mainly on repurposed immunomodulatory and antiviral agents along with the availability of a few vaccines for prophylaxis to vanquish...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Heliyon
Asıl Yazarlar: Jeyaraman, Madhan, Muthu, Sathish, Bapat, Asawari, Jain, Rashmi, Sushmitha, E.S., Gulati, Arun, Channaiah Anudeep, Talagavadi, Dilip, Shirodkar Jaswandi, Jha, Niraj Kumar, Kumar, Dhruv, Kesari, Kavindra Kumar, Ojha, Shreesh, Dholpuria, Sunny, Gupta, Gaurav, Dureja, Harish, Chellappan, Dinesh Kumar, Singh, Sachin Kumar, Dua, Kamal, Jha, Saurabh Kumar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8294777/
https://ncbi.nlm.nih.gov/pubmed/34312598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2021.e07635
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller